- Home
- ENTG vs QGEN Comparison
ENTG vs QGEN Comparison
Compare ENTG & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTG
- QGEN
- Stock Information
- Founded
- ENTG 1966
- QGEN 1986
- Country
- ENTG United States
- QGEN Netherlands
- Employees
- ENTG N/A
- QGEN N/A
- Industry
- ENTG Plastic Products
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ENTG Industrials
- QGEN Health Care
- Exchange
- ENTG Nasdaq
- QGEN Nasdaq
- Market Cap
- ENTG 13.9B
- QGEN 10.1B
- IPO Year
- ENTG 2000
- QGEN 1996
- Fundamental
- Price
- ENTG $93.01
- QGEN $49.34
- Analyst Decision
- ENTG Buy
- QGEN Buy
- Analyst Count
- ENTG 11
- QGEN 8
- Target Price
- ENTG $107.09
- QGEN $50.68
- AVG Volume (30 Days)
- ENTG 2.2M
- QGEN 955.8K
- Earning Date
- ENTG 10-30-2025
- QGEN 11-04-2025
- Dividend Yield
- ENTG 0.44%
- QGEN 3.06%
- EPS Growth
- ENTG 60.99
- QGEN 405.09
- EPS
- ENTG 1.95
- QGEN 1.69
- Revenue
- ENTG $3,223,108,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- ENTG $0.67
- QGEN $7.37
- Revenue Next Year
- ENTG $8.09
- QGEN $5.74
- P/E Ratio
- ENTG $46.94
- QGEN $29.13
- Revenue Growth
- ENTG N/A
- QGEN 5.15
- 52 Week Low
- ENTG $60.75
- QGEN $37.63
- 52 Week High
- ENTG $112.36
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- ENTG 52.51
- QGEN 69.30
- Support Level
- ENTG $87.00
- QGEN $48.34
- Resistance Level
- ENTG $94.80
- QGEN $49.59
- Average True Range (ATR)
- ENTG 4.49
- QGEN 0.75
- MACD
- ENTG -0.50
- QGEN 0.27
- Stochastic Oscillator
- ENTG 51.17
- QGEN 91.88
About ENTG Entegris Inc.
Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).